2025/10/25 by Shengfeng Deng, Guo Mu, Jun Li +3 · 1 voice
Biochemistry, Genetics and Molecular Biology · Medicine · Neuroscience · #Anesthesia and Neurotoxicity Research #Peptidase Inhibition and Analysis #RNA modifications and cancer
paper · doi:10.1016/j.jphyss.2025.100048
openalex created_date 2025/10/25 · openalex publication_date 2025/10/25 · openalex updated_date 2026/07/23
To investigate the mechanisms underlying sevoflurane-induced POCD, C57BL/6 J mice and SH-SY5Y cells were treated with sevoflurane for model establishment. After the treatment with sevoflurane, CCK-8, EdU and flow cytometry were employed to detect cell damage. The levels of N6-methyladenosine (m6A), METTL14 and DUSP6 were determined by qPCR and Western blot. The interaction between METTL14 and DUSP6 was analyzed using RIP-qPCR and Me-RIP methodologies. The cognitive function in mice were assessed by water maze test. After sevoflurane treatment, the cell viability, cell proliferation and METTL14 expression were markedly suppressed, while apoptosis was significantly enhanced. METTL14 overexpression elevated the levels of m6A and DUSP6, increased the binding level of METTL14 to DUSP6 mRNA, reducing damage to cells and cognitive dysfunction of mice. Knockdown of DUSP6 negated the beneficial effects observed with METTL14 overexpression. Sevoflurane induced POCD by regulating METTL14/DUSP6 through m6A methylation. • Sevoflurane suppressed cell growth and induced apoptosis in vivo and in vitro. • Sevoflurane induced postoperative cognitive dysfunction by regulating METTL14/DUSP6 through m6A methylation • Overexpression of METTL14 and DUSP6 can alleviate postoperative cognitive dysfunction caused by Sevoflurane.